1. 654 Real world incidence of grade III and higher adverse effects, emergency room utilization and hospital admissions during treatment with commonly used PD-1/PDL-1 targeting immune check point inhibitors. (9th November 2020) Authors: Lia, Nerea Lopetegui; Jafri, Syed Imran; Shalaby, Khalid; Drekolias, Dimitrios; Vredenburgh, James Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A392 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 654 Real world incidence of grade III and higher adverse effects, emergency room utilization and hospital admissions during treatment with commonly used PD-1/PDL-1 targeting immune check point inhibitors. (9th November 2020) Authors: Lia, Nerea Lopetegui; Jafri, Syed Imran; Shalaby, Khalid; Drekolias, Dimitrios; Vredenburgh, James Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A691 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ACTR-40. PHASE 2 SAFETY AND EFFICACY OF AR-67 (7-T-BUTYLDIMETHYLSILTYL-10-HYDROXYCAMPTOTHECIN) IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME (GBM) OR GLIOSARCOMA. (11th November 2019) Authors: Kumthekar, Priya; Raizer, Jeffrey; Cavaliere, Robert; Devoe, Craig; Jensen, Randy; Stieber, Volker; Runk, Tina; Grewal, Jai; Brownell, Elise; Zukiwski, Alex; Proniuk, Stefan; Arnold, Susanne; Vredenburgh, James Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ado-trastuzumab emtansine: Avoiding side-effects of traditional HER2 positive breast cancer treatment. (October 2021) Authors: Turshudzhyan, Alla; Vredenburgh, James Journal: Journal of oncology pharmacy practice Issue: Volume 27:Number 7(2021) Page Start: 1770 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CTIM-10. REPRODUCIBILITY OF CLINICAL TRIALS USING CMV-TARGETED DENDRITIC CELL VACCINES IN PATIENTS WITH GLIOBLASTOMA. (12th November 2021) Authors: Batich, Kristen; Mitchell, Duane; Healy, Patrick; Herndon, James; Broadwater, Gloria; Michael, Gunn; Huang, Min-Nung; Hotchkiss, Kelly; Sanchez-Perez, Luis; Nair, Smita; Congdon, Kendra; Norberg, Pam; Weinhold, Kent; Archer, Gary; Reap, Elizabeth; Xie, Weihua; Shipes, Steven; Albrecht, Emily; Pet... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. New onset diabetes with ketoacidosis following nivolumab immunotherapy: A case report and review of literature. (April 2021) Authors: Delasos, Lukas; Bazewicz, Christopher; Sliwinska, Aleksandra; Lia, Nerea Lopetegui; Vredenburgh, James Journal: Journal of oncology pharmacy practice Issue: Volume 27:Number 3(2021) Page Start: 716 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma. Issue 11 (4th October 2019) Authors: Ghobrial, Irene M.; Liu, Chia‐Jen; Zavidij, Oksana; Azab, Abdel K.; Baz, Rachid; Laubach, Jacob P.; Mishima, Yuji; Armand, Philippe; Munshi, Nikhil C.; Basile, Frank; Constantine, Michael; Vredenburgh, James; Boruchov, Adam; Crilley, Pamela; Henrick, Patrick M.; Hornburg, Kalvis T. V.; Leblebjian... Journal: American journal of hematology Issue: Volume 94:Issue 11(2019:Nov.) Page Start: 1244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma. (17th April 2018) Authors: Affronti, Mary Lou; Jackman, Jennifer Gamboa; McSherry, Frances; Herndon, James E.; Massey, Elwood C.; Lipp, Eric; Desjardins, Annick; Friedman, Henry S.; Vlahovic, Gordana; Vredenburgh, James; Peters, Katherine B. Journal: Oncologist Issue: Volume 23:Number 8(2018) Page Start: 889 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Primary Bone Lymphoma: A Case Series and Review of Literature. (10th April 2020) Authors: Bindal, Poorva; Desai, Aakash; Delasos, Lukas; Mulay, Sudhanshu; Vredenburgh, James Other Names: González-López Tomás J. Academic Editor. Journal: Case reports in hematology Issue: Volume 2020(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Primary central nervous system diffuse large B‐cell lymphoma masqueraded as Bing‐Neel syndrome: Steps in management and review of future directions. Issue 12 (6th December 2021) Authors: Delasos, Lukas; Phachu, Deep; Shetty, Nishka; Sepulveda‐Ramos, Melissa; Vredenburgh, James Journal: Clinical case reports Issue: Volume 9:Issue 12(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗